5 news items
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
CKPT
HRT
OCGN
16 May 24
, 2024 Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
CKPT
HRT
OCGN
12 May 24
is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
CKPT
HRT
OCGN
7 May 24
Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel
HireRight Reports First Quarter 2024 Results
HRT
7 May 24
of financing; and increased cybersecurity requirements, vulnerabilities, threats and more sophisticated and targeted cyber-related attacks that could pose
HireRight Reports Fourth Quarter and Full-Year 2023 Results
HRT
12 Mar 24
cybersecurity requirements, vulnerabilities, threats and more sophisticated and targeted cyber-related attacks that could pose a risk to our systems
- Prev
- 1
- Next